Skip to content

Drug interactions

Etravirine + Nateglinide

Severity: Moderate

Etravirine and Nateglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etravirine inhibits CYP2C9 and CYP2C19 and induces CYP3A4, so it may raise nateglinide exposure through reduced CYP2C9 clearance. This could increase hypoglycemia risk. The effect of nateglinide on etravirine is unlikely to matter clinically.

What this interaction means in plain words

Etravirine and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Etravirine belongs to Anti Virals; Nateglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Etravirine inhibition of CYP2C9-mediated nateglinide metabolism, partly offset by CYP3A4 induction.

What to do

Monitor blood glucose for hypoglycemia after starting etravirine. Reduce the nateglinide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Etravirine and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Etravirine with Nateglinide?

MediHelp rates the interaction as moderate. Etravirine and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Etravirine inhibits CYP2C9 and CYP2C19 and induces CYP3A4, so it may raise nateglinide exposure through reduced CYP2C9 clearance. This could increase hypoglycemia risk. The effect of nateglinide on etravirine is unlikely to matter clinically.

How serious is the interaction between Etravirine and Nateglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose for hypoglycemia after starting etravirine. Reduce the nateglinide dose if hypoglycemia occurs.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in